Showing results (81-90 of 17,175) with videos related to
Sort By:
Pageof 1,718
Current Opinion in Rheumatology|April 4, 2026
Pathogenesis-directed lupus therapeuticsBhavya Poudyal, Andras PerlFrontiers in Immunology|March 25, 2021
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8<sup>+</sup> T Cells <i>via</i> STAT6-GATA-3 Axis in Systemic Lupus ErythematosusHiroshi Kato, Andras PerlClinical Immunology (Orlando, Fla.)|June 18, 2021
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patientsParamarajan Piranavan, Andras PerlClinical Immunology (Orlando, Fla.)|January 13, 2006
The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosusGyorgy Nagy, Andras PerlJournal of Clinical Pharmacy and Therapeutics|February 1, 1996
The impact of clinical pharmacy intervention in a psychiatric hospitalA Dorevitch, E PerlExpert Opinion on Pharmacotherapy|June 10, 2009
Pharmacotherapy of systemic lupus erythematosusLisa Francis, Andras PerlThe Journal of Clinical and Aesthetic Dermatology|November 6, 2014
Actinic keratosis: update on field therapyGary Goldenberg, Marcel PerlJournal of Immunology (Baltimore, Md. : 1950)|April 1, 2014
Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosusHiroshi Kato, Andras PerlCurrent Opinion in Rheumatology|March 29, 2019
Pathogenesis and treatment of autoimmune rheumatic diseasesEric Liu, Andras PerlPageof 1,718